나노 입자를 이용한 약물전달체계의 개선 및 암치료

참고문헌 (109)

1. "Targeted therapies for cancer 2004", 122(4), pp.598~609 (2004)
2. "Resistance to epidermal growth factor receptor-targeted therapy", 8(5), pp.298~310 (2005)
3. "Multidrug resistance in cancer: Role of ATP-dependent transporters", 2(1), pp.48~58 (2002)
4. "Brain uptake of thiamine-coated nanoparticles", 93(3), pp.271~282 (2003)
5. "Biodegradable nanoparticles for drug and gene delivery to cells and tisue", 55(3), pp.329~347 (2003)
6. "Nanotechnology in cancer the-rapeutics: Bioconjugated nanoparticles for drug delivery", 5(8), pp.1909~1917 (2006)
7. "The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting", 41, pp.189~207 (2001)
8. "Ligand-targeted therapeutics in anticancer therapy", 2(10), pp.750~763 (2002)
9. "Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture", pp.1263~8
10. "Resistance mechanisms asociated with altered intracellular distribution of anticancer agents", 85(3), pp.217~229 (2000)
11. "Nanocarriers: Promising ve-hicle for bioactive drugs", 29(9), pp.1790~1798 (2006)
12. "Polymer conjugates: Nanosized medicines for treating cancer", 24(1), pp.39~47 (2006)
13. "Taxol suppresses dynamics of individual microtubules in living human tumor cels", 10(4), pp.947~959 (1999)
14. "Synthesis and in vivo antitumor activity of poly con-jugates of 20S-camptothecin"
15. "Cremophor EL: The drawbacks and advantages of vehicle selection for drug formula-tion", 37(13), pp.1590~1598 (2001)
16. "Phase II trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer", 23(31), pp.7794~7803 (2005)
17. "Abraxane, a novel Cremophor-fre, albumin-bound par-ticle form of paclitaxel for the treatment of advanced non-smal-cel lung cancer", 17(8), pp.1263~1268 (2006)
18. "Phase I clinical and pharmacokinetic study of PK1 [N- First member of a new class of chemotherapeutic agents-drug-polymer conjugates", pp.2 83~94, Clin Cancer Res 19
19. "Poly(L-glutamic acid)-anticancer drug conjugates", 54(5), pp.695~713 (2002)
20. "Phase II study of CT-2103 in patients with recurrent epithe-lial ovarian, falopian tube, or primary peritoneal carcinoma", 22(22), pp.4523~4531 (2004)
21. "Efficacy and safety of paclitaxel poliglumex as first-line chemothera-py in patients at high risk with advanced-stage non-small-cell lung cancer: Results of a phase I study", 7(3), pp.215~220 (2005)
22. "Synthesis and in vivo antitumor activity of poly(l-glutamic acid) con-jugates of 20S-camptothecin", 46(1), pp.190~193 (2003)
23. "Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and eficacy in vivo", 74(1-3), pp.243~247 (2001)
24. "Efectiveness of water soluble poly(L-glutamic acid)-camptothecin conjugate against resistant human lung cancer xenografted in nude mice", 18(2), pp.331~336 (2001)
25. "The dawning era of polymer therapeutics", 2(5), pp.347~360 (2003)
26. "Dendrimers in biomedical aplications-reflections on the field", pp.2106~29
27. "Amphiphilic block copolymers for drug delivery", 92(7), pp.1343~1355 (2003)
28. "Anthracycline antibiotics non-covalently incorporated into the block copolymer miceles: In vivo evaluation of anti-cancer activity", 74(10), pp.1545~1552 (1996)
29. "Development of the polymer micelle carrier system for doxorubicin", 74(1-3), pp.295~302 (2001)
30. "In vivo evaluation of polymeric micelar paclitaxel formulation: Toxicity and efficacy", 72, pp.191~202 (2001)
31. "Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micele-formulated paclitaxel, in patients with advanced malignancies", 10(11), pp.3708~3716 (2004)
32. "Randomized phase III trial of liposomal daunorubicin versus doxorubicin and vincristine in AIDS-related Ka-posis sarcoma", pp.2353~64
33. "Designing dendrimers for biological applications", 23(12), pp.1517~1526 (2005)
34. "Dendrimers in biomedical aplications-reflections on the field", 57(15), pp.2106~2129 (2005)
35. "Dendrimer-platinate: A novel approach to cancer chemotherapy", 10(8), pp.767~776 (1999)
36. "Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial 조광재", 65(12), pp.5317~5324 (2005)
37. "Aplications of carbon nanotubes in drug delivery", pp.674~9
38. "Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary", 7(11), pp.1467~1474 (2006)
39. "Curent status of liposomal anthracycline therapy in me-tastatic breast cancer", 4, pp.S76~S83 (2003)
40. "Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Ka-posis sarcoma", 14(8), pp.2353~2364 (1996)
41. "Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma", 25(1), pp.57~59 (2002)
42. "Liposomal en-capsulated anti-cancer drugs", 16(7), pp.691~707 (2005)
43. "The role of the sinus wal in the pasage of ery-throcytes through the spleen", pp.529~37
44. "Biomedical appli-cations of functionalised carbon nanotubes", (5), pp.571~577 (2005)
45. "Aplications of carbon nanotubes in drug delivery", 9(6), pp.674~679 (2005)
46. "Targeted delivery of amphotericin B to cels by using func-tionalized carbon nanotubes", 44(39), pp.6358~6362 (2005)
47. "Double functionalisation of carbon nanotubes for multimodal drug delivery", (11), pp.1182~1184 (2006)
48. "Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction", 102(33), pp.11600~11605 (2005)
49. "Long-circulating and target-specific nanoparticles: Theory to practice", 53(2), pp.283~318 (2001)
50. "Lymphotropic nanopar-ticle enhanced MR imaging (LNMRI) technique for lymph node im-aging", 58(3), pp.367~374 (2006)
51. "Angiogenesis in cancer and other diseases", pp.249~57
52. "Structure and function of sinusoidal lining cels in the liver", 24(1), pp.100~101 (1996)
53. "Vascular permeability in a human tumor xenograft: Molecular size dependence and cutof size", 55(17), pp.3752~3756 (1995)
54. "Stealth liposomes and long circulating nanoparticles: Critical isues in pharmacokinetics, opsonization and protein-binding properties", 42(6), pp.463~478 (2003)
55. "Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups", 18(1), pp.1~8 (2001)
56. "Biodis-tribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system", 202(1-2), pp.1~10 (2000)
57. "Pegylation: A novel process for mo-difying pharmacokinetics", 40(7), pp.539~551 (2001)
58. "Angiogenesis in cancer and other diseases", 407(6801), pp.249~257
59. "Glycolysis inhibition for anticancer treatment", 25(34), pp.4633~4646 (2006)
60. "Antibody targeting of doxorubicin-loaded liposomes suppreses the growth and metastatic spread of established human lung tumor xenografts in severe combined imunodeficient mice", suga(m), pp.6942~9
61. "Targeted prodrug design to optimize drug de-livery", 2(1), pp.E6~ (2000)
62. "A new approach for the treatment of malignant melanoma: Enhanced antitumor efficacy of an albumin-binding doxorubicin pro-drug that is cleaved by matrix metaloproteinase 2", 63(14), pp.4062~4066 (2003)
63. "Selection of tumor-specific internalizing human antibodies from phage libraries", pp.1149~61
64. "Liposome targeting to tumors using vitamin and growth factor receptors", 60, pp.285~332 (2000)
65. "Human anti-mouse antibody response in cancer patients folowing single low-dose injections of radiolabeled murine monoclonal antibodies", pp.17~28
66. "Imunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo", pp.177~80
67. "Targeting of stealth liposomes to erbB-2 (Her", 2) receptor: In vitro and in vivo studies, 1996, pp.74(11), 1749~1756
68. "Antibody targeting of doxorubicin-loaded liposomes suppreses the growth and metastatic spread of established human lung tumor xenografts in severe combined imunodeficient mice", 60(24), pp.6942~6949 (2000)
69. "Folate-targeted chemotherapy", 56(8), pp.1127~1141 (2004)
70. "Ligand binding and kinetics of folate receptor recycling in vivo: Impact on re-ceptor-mediated drug delivery", 66(6), pp.1406~1414 (2004)
71. "Selection of tumor-specific internalizing human antibodies from phage libraries", 301(5), pp.1149~1161 (2000)
72. "Liposome targeting to tumors using vitamin and growth factor receptors", 60, pp.285~332 (2000)
73. "Application of locked nucleic acids to improve aptamer in vivo stability and targeting function", pp.5757~65
74. "Imunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo", 413(1), pp.177~180 (1997)
75. "A new approach for targeting prostate cancer cells", na(particle-aptamer bioconjugates), pp.7668~72
76. "Folate receptor-mediated drug targeting: From therapeutics to diagnostics", 94(10), pp.2135~2146 (2005)
77. "Examining expression of folate receptors in squamous cell carcinoma of the head and neck (SCCHN) as a target for nanotherapeutic drugs" (2007)
78. "Investigation of taxol-resistance using folate-targeted ternary thera-peutic nanoparticle" (2007)
79. "Tumor targeting by an aptamer", 47(4), pp.668~678 (2006)
80. "Aptamers as therapeutic and diagnostic agents", 74(1), pp.5~13 (2000)
81. "Application of locked nucleic acids to improve aptamer in vivo stability and targeting function", 32(19), pp.5757~5765 (2004)
82. "Neutralizing aptamers from whole-cel SELEX inhibit the RET receptor tyrosine kinase", 3(4), pp.e123~ (2005)
83. "Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells", 64(21), pp.7668~7672 (2004)
84. "nanoparticle-aptamer bioconjugates for cancer chemothe-rapy in vivo", 103(16), pp.6315~6320 (2006)
85. "Mechanisms of iron uptake by mamalian cells", 1269(3), pp.205~214 (1995)
86. "Targeted drug delivery via the trans-ferin receptor-mediated endocytosis pathway", 54(4), pp.561~587 (2002)
87. "Mechanisms of TfR-mediated transcytosis and sorting in epithelial cels and aplications toward drug delivery", 55(11), pp.1439~1466 (2003)
88. "Enhanced antiproliferative activity of transferin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracelular drug retention", 2(5), pp.373~383 (2005)
89. "Targeted drug delivery to C6 glioma by transferin-coupled liposomes", 51(1), pp.10~14 (2000)
90. "Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo", 18(7), pp.1042~1048 (2001)
91. "Intracellular targeting therapy of cisplatin-encapsulated transfer-rin-polyethylene glycol liposome on peritoneal disemination of gas-tric cancer", 99(1), pp.130~137 (2002)
92. "Lectin-mediated drug targeting: History and applications", 56(4), pp.425~435 (2004)
93. "Drug targeting to the colon with lectins and neoglycoconju-gates", 56(4), pp.491~509 (2004)
94. "Mechanism of pluronic efect on P-glycoprotein eflux system in blod-brain barier Contributions of energy depletion and membrane fluidization", vi kaba(gradov sv v av), pp.483~93
95. "Pluronic block copolymers alter apoptotic signal transduction of dox-orubicin in drug-resistant cancer cels", pp.269~78
96. "Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin", 20(6), pp.1668~1676 (2002)
97. "Tumor physiology and drug resistance", 20(1-2), pp.123~132 (2001)
98. "Drug resistance and the microenvironment: Nature and nurture", 6(4), pp.169~172 (2003)
99. "Molecular determinants of sensitivity to antitumor agents", 1424(1), pp.R37~R42 (1999)
100. "A mechanistic study of enhanced doxorubicin uptake and re-tention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system", 317(3), pp.1372~1381 (2006)
101. "Drug delivery to resistant tumors: The potential of poly (alkyl cyanoacry-late) nanoparticles", 93(2), pp.151~160 (2003)
102. Batrakova EV, "Mechanism of pluronic efect on P-glycoprotein eflux system in blod-brain barier: Contributions of energy depletion and membrane fluidization", 299(2), pp.483~493 (2001)
103. Minko T, "Pluronic block copolymers alter apoptotic signal transduction of dox-orubicin in drug-resistant cancer cels", 105(3), pp.269~278 (2005)
104. Lee ES, "Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor", 103(2), pp.405~418 (2005)
105. "Contributions of advanced pro-eomics technologies to cancer dia"
106. Medintz IL, "Quantum dot bioconjugates for imaging, labeling and sensing", 4(6), pp.435~446 (2005)
107. Gao X, "In vivo cancer", 22(8), pp.969~976 (2004)
108. Cho YW, "In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications", 28(6), pp.1236~1247 (2007)
109. Seo WS, "FeCo", graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents, 2006, pp.5(12), 971~976

관련 논문AI추천